Awareness and prescribing of the Wegovy pill for weight loss surge among primary care physicians and endocrinologists following its January launch.Exton, PA, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The ...
AUSTIN, TX, UNITED STATES, January 27, 2026 /EINPresswire.com/ -- Omnia Health Solutions, LLC (“Omnia”), a real-world ...
The results of 2 recent clinical trials combining the GLP-1 drug and the biologic reinforce the benefits of treating obesity ...
Eli Lilly and Company LLY is one of the two clear leaders in the rapidly expanding diabetes and obesity treatment market, ...
New approaches to obesity treatment are emerging as scientists target underexplored metabolic pathways with the help of artificial intelligence. Demand for better obesity medicines is rising quickly, ...
Research shows that metabolic surgery and GLP-1 medications are both effective therapies for treating obesity. Medications ...
Eli Lilly and Company (NYSE: LLY) is one of the best growth stocks to buy for the next 20 years. On February 18, Eli Lilly ...
With their blockbuster obesity drugs, Eli Lilly and Novo Nordisk have uncovered a variety of ailments the incretin treatments can combat. | Six weeks after Eli Lilly revealed the success of phase 3b ...
The AACE consensus statement emphasizes improvement of overall health in addition to weight reduction among adults with obesity and adiposity-based chronic disease.
Researchers are applying insights into the genetic variations and physiology of obesity to apply tailored interventions to ...
In every single state, researchers expect at least 35% of adults to have a body mass index of 30 or higher, the threshold ...
Wave Life Sciences Ltd. (NASDAQ:WVE) is one of the 13 hot stocks to buy with the highest upside potential. On February 5, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results